PREVIOUS QUESTION:

 

NEXT QUESTION:

 

How does ribociclib treat breast cancer?

ANSWER

Ribociclib (Kisqali) is used in combination with an aromatase inhibitor as initial hormone therapy in women who have gone through menopause who have hormone receptor positive, HER2-negative advanced breast cancer.

SOURCES:

National Cancer Institute.

Breastcancer.org.

Medscape. 

Pfizer Inc.

Reviewed by Laura J. Martin on November 11, 2017

SOURCES:

National Cancer Institute.

Breastcancer.org.

Medscape. 

Pfizer Inc.

Reviewed by Laura J. Martin on November 11, 2017

NEXT QUESTION:

Which hormone drugs treat breast cancer?

WAS THIS ANSWER HELPFUL

THIS TOOL DOES NOT PROVIDE MEDICAL ADVICE. It is intended for general informational purposes only and does not address individual circumstances. It is not a substitute for professional medical advice, diagnosis or treatment and should not be relied on to make decisions about your health. Never ignore professional medical advice in seeking treatment because of something you have read on the WebMD Site. If you think you may have a medical emergency, immediately call your doctor or dial 911.

    This tool does not provide medical advice. See additional information.

    Other Answers On: